Breast Cancer Pathology: What Indian Labs Should Know

Creator: Unimeditrek Editorial Team
Published: 2026-06-16T20:19:59.171Z

16 June 2026

Written by Unimeditrek Editorial Team

Last updated 30 June 2026

In short

Breast cancer reporting hinges on accurate grading plus reliable ER, PR and HER2 status — all of which are exquisitely sensitive to fixation and ischaemia time.

For doctors

Reproducible ER/PR/HER2 demands controlled cold ischaemia time and standardised fixation in neutral buffered formalin, adequate fixation duration, and validated IHC with controls. These predictive markers directly determine endocrine and anti-HER2 therapy eligibility.

For patients

Breast cancer testing checks hormone receptors and HER2 to choose the right treatment. Careful tissue handling makes these results dependable.

Why the pre-analytics are decisive

Breast cancer management is biomarker-driven. ER, PR and HER2 status select patients for endocrine therapy and anti-HER2 agents — so a technically unreliable result has direct therapeutic consequences.

What the lab controls

Cold ischaemia time: minimise the interval to fixation to protect labile receptors.
Fixation: neutral buffered formalin, with adequate (not excessive) duration.
Validated IHC: appropriate controls and standardised scoring.

Grading still matters

Histological grade remains a core prognostic input and depends on clean, well-stained sections that show nuclear detail and mitoses clearly.

The quality thread

From the moment tissue arrives, standardised fixation and processing protect both morphology and biomarker integrity. Reliable equipment and consistent staining are what make breast biomarker reporting defensible.

Key takeaways

ER, PR and HER2 directly guide breast cancer therapy.
Cold ischaemia time and fixation make-or-break biomarker reliability.
Grade depends on clean, well-stained sections.
Standardised pre-analytics protect both morphology and markers.

Related equipment

Automated Slide Stainer · LSM-520

Unimeditrek Automated Slide Stainer LSM-520 — programmable linear staining system for H&E and special stains, delivering

View product

Fully Automated Vacuum Tissue Processor · VTP-300

Unimeditrek Kshriom Series VTP 300 sets new standards by achieving finer specimen processing on each run. This latest st

View product

FAQs

Why is cold ischaemia time emphasised in breast cancer?

Hormone-receptor epitopes degrade with delay to fixation, risking falsely low ER/PR results that change treatment.

Is grading still relevant with biomarkers?

Yes — histological grade remains an independent prognostic factor.

Standards & further reading

Authoritative references for further reading. This article is an original summary and does not reproduce text from these sources.

Disclaimer. This content is for educational purposes only and is not a substitute for professional medical advice, diagnosis or treatment. Patients should consult their doctor for medical decisions.
This summary is based on publicly available source metadata and original analysis. Readers should refer to the original publication for full scientific details.

Talk to experts

Build or upgrade your pathology lab

Request a quote, a free demo, or a complete lab-setup plan. Our team replies within one working day.